Your Voice. Their Blueprint.
Patient-Focused Drug Development(PFDD) means a powerful way for families, caregivers, and people living with a disease to directly tell regulatory decision-makers and treatment developers what living with that condition is really like.
PFDD is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation.
This is your chance to shape future treatment options with your voice.
Read on below or download our info sheet here.
-
The Goal
To host an externally-led PFDD (El-PFDD) meeting for Alexander Disease, with regulatory decision-makers attending in a listening role.
Uncover the real-life impact, unmet needs, and hopes for the future.
Result in a formal “Voice of the Patient” report that becomes part of the public record.
-
Who should participate?
Patients living with AxD - newly diagnosed, early onset, adolescent, young adult, adult
Caregivers and family members of all ages
Siblings, loved ones, and advocates
Bereaved families whose voices still deeply matter
Anyone with lived experience, regardless of diagnosis timeline or disease stage
-
What happens next?
Immediately
Planning kicks off
Identification of participants who express interest in sharing their voice to support the EL-PFDD process
July through December
Monthly check-ins with the End AxD board.
Organize panels, survey the community, and prep materials.
Align with the End AxD board to plan a virtual Zoom session with regulatory participants based on the provided timeframe
-
How you can help?
Share your story
Join our contact registry
Add your name to the Patient Advocacy support list by emailing: info@endaxd.org
Help spread the word about the EL-PFDD to fellow AxD families
-
Key takeaways
This meeting does not Involve giving approval or clinical direction - it’s for sharing and listening; for looking into the lives of those affected by AxD
It’s hosted by the AxD community, not regulators
Sharing your story increases our chances for the Alexander Disease Community
to be heard and to be prioritizedfor consideration of medical treatments and breakthroughs